Tenet Healthcare Q4 Earnings Beat Expectations on Strong Payer Mix

Tenet Healthcare Corporation (THC) delivered robust fourth-quarter 2025 results, with adjusted earnings per share (EPS) of $4.70 significantly outpacing analyst expectations by 15.2%. This strong performance reflects the company’s ability to optimize its payer mix while managing operational complexities. Net operating revenues climbed 8.9% year over year to $5.53 billion, also surpassing consensus estimates by 1.4%, demonstrating solid top-line momentum driven by improved acuity and higher same-facility revenues across the portfolio.

The quarter’s success was anchored by multiple operational tailwinds. A favorable payer mix, combined with improved patient acuity and prudent cost management, offset headwinds from rising supply expenses. Facility acquisitions in the Ambulatory Care segment further bolstered overall performance, yet mounting operating costs—particularly in supplies—partially dampened the upside potential.

Hospital Operations Lead Growth Through Payer Mix Optimization

The Hospital Operations and Services segment posted net operating revenues of $4.09 billion, reflecting a 7.3% year-over-year increase that beat internal estimates by approximately $80 million. This expansion was powered by enhanced Medicaid supplemental revenues, elevated patient acuity levels, and a favorable payer mix that allowed the company to command better pricing and service mix economics.

Adjusted EBITDA in this core segment surged 16.4% year over year to $603 million, with an expanded adjusted EBITDA margin of 14.7%—up 110 basis points from the prior year. This margin expansion underscores the positive leverage from payer mix improvements, as higher-reimbursement patient volumes more than offset incremental operating expenses. Salaries, wages, and benefits costs increased 6.1% year over year to $2.2 billion, while supply costs rose 8.6%, demonstrating the persistent inflationary pressures in healthcare labor and materials.

Ambulatory Care Segment Achieves Revenue Growth Amid Margin Compression

The Ambulatory Care segment delivered net operating revenues of $1.43 billion, up 13.8% year over year and exceeding estimates by approximately $70 million. This robust growth was fueled by improved same-facility net patient services revenues, strategic facility acquisitions, and expanded service line offerings that enhanced payer mix diversity.

However, investors should note that adjusted EBITDA margin in Ambulatory Care deteriorated 160 basis points year over year to 40.5%, despite absolute EBITDA growth of 9.4% to $580 million. This margin compression reflects elevated operating expenses relative to revenue growth—a dynamic worth monitoring closely as the company navigates 2026 operations. The segment’s margin pressure suggests that payer mix improvements may not be fully offsetting cost inflation in this higher-margin business.

Strengthened Financial Position Supports Growth Investments

Tenet Healthcare exited 2025 with a fortified balance sheet. Cash and cash equivalents totaled $2.88 billion, while total assets reached $29.7 billion. Long-term debt, net of current portions, stood at $13.1 billion with a current portion of $79 million. Shareholders’ equity improved to $4.22 billion from $4.17 billion at year-end 2024.

Most impressively, operating cash flow surged 72.9% year over year to $3.5 billion in 2025, while free cash flow nearly doubled, rising 126.7% to $2.5 billion. This exceptional cash generation reflects not only higher profitability but also improved working capital management. The company allocated $1.4 billion toward share repurchases in 2025, with an additional $1.49 billion remaining under authorization.

2026 Guidance Points to Revenue Growth but Margin Headwinds

Management projects 2026 net operating revenues between $21.5 billion and $22.3 billion, modestly above the $21.3 billion achieved in 2025. Hospital Operations revenues are expected to fall between $16 billion and $16.6 billion, while Ambulatory Care is forecasted to generate $5.5 billion to $5.7 billion.

Adjusted EBITDA is guided to the $4.485 billion to $4.785 billion range, compared with 2025’s $4.566 billion. Notably, adjusted EBITDA margin is expected to compress to 20.9-21.5%, compared with 2025’s 21.4% result. This margin pressure—despite stable to slightly rising revenue—suggests that payer mix normalization and cost inflation may weigh on profitability in the year ahead. Adjusted EPS is expected to range from $16.19 to $18.47, down from $16.78 in 2025.

Operating cash flow is projected between $3.64 billion and $4.09 billion, while free cash flow is expected to range from $2.94 billion to $3.29 billion. Capital expenditures are budgeted at $700-$800 million, indicating measured investment in infrastructure and technology enhancements.

Peer Medical Operators Show Mixed Performance Signals

Tenet’s results follow similar earnings releases from other medical healthcare providers, revealing an industry adapting to shifting reimbursement dynamics.

HCA Healthcare reported fourth-quarter 2025 adjusted EPS of $8.01, exceeding consensus by 8.8%, driven by robust admission volumes, modest emergency department growth, and improved revenue per equivalent admission. Elevated operating expenses partially offset these gains, reflecting industry-wide cost pressures similar to those impacting Tenet.

The Ensign Group delivered adjusted EPS of $1.82, beating expectations by 4%, supported by higher occupancy rates and increased skilled nursing service volumes. Like Tenet, Ensign faced headwinds from rising expenses despite operational improvements.

Encompass Health reported adjusted EPS of $1.46, surpassing guidance by 13.2%, on the back of higher net revenue per discharge and increased discharge volumes across both inpatient and other revenue streams. Operating expense growth again moderated the magnitude of upside, consistent with the broader sector experience.

These peer results underscore that healthcare operators across the spectrum are leveraging payer mix optimization and operational efficiency to navigate an inflationary environment, though margin expansion remains constrained by cost pressures. Tenet Healthcare currently carries a Zacks Rank of #3 (Hold), reflecting the balanced opportunity and risk profile heading into 2026.